REVA Medical Inc. CDI | Income Statement
Fiscal year is January-December. All values AUD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
-
-
-
-
58.70
Cost of Goods Sold (COGS) incl. D&A
924.90
1,139.50
1,460.60
1,532.20
1,440.30
Gross Income
924.90
1,139.50
1,460.60
1,532.20
1,381.60
SG&A Expense
28,048.80
23,228.50
30,483.10
34,491.70
26,444.30
EBIT
28,973.70
24,367.90
31,943.70
36,023.80
27,825.90
Unusual Expense
-
31,253.50
75,678.80
33,961.70
45,936.40
Non Operating Income/Expense
9.30
81.00
78.60
28.30
150.00
Interest Expense
-
1,094.00
2,537.40
2,761.60
8,727.80
Pretax Income
28,952.00
56,625.50
110,069.30
72,771.30
9,307.00
Consolidated Net Income
28,952.00
56,625.50
110,069.30
72,771.30
9,307.00
Net Income
28,952.00
56,625.50
110,069.30
72,771.30
9,307.00
Net Income After Extraordinaries
28,952.00
56,625.50
110,069.30
72,771.30
9,307.00
Net Income Available to Common
28,952.00
56,625.50
110,069.30
72,771.30
9,307.00
EPS (Basic)
-
1.70
3.17
-
-
Basic Shares Outstanding
331,246.60
333,823.80
346,806.30
421,205.50
418,113.30
EPS (Diluted)
0.09
0.17
0.32
0.17
0.05
Diluted Shares Outstanding
331,246.60
333,823.80
346,806.30
421,205.50
533,174.80
EBITDA
28,048.80
23,228.50
30,483.20
34,491.70
26,440.40
Non-Operating Interest Income
31.10
8.90
12.00
4.00
74.40
About REVA Medical
View Profile
